Publicacións en colaboración con investigadores/as de University of Turin (17)

2015

  1. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460

2010

  1. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes

    Endocrinology, Vol. 151, Núm. 7, pp. 3286-3298

2008

  1. Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegaly

    Journal of Endocrinological Investigation, Vol. 31, Núm. 12, pp. 1103-1109

2007

  1. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients

    Journal of Endocrinological Investigation, Vol. 30, Núm. 10, pp. 844-852

2004

  1. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients

    Clinical Endocrinology, Vol. 61, Núm. 2, pp. 250-255

2003

  1. Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity

    Clinical Endocrinology, Vol. 58, Núm. 2, pp. 220-228

  2. Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level

    Journal of Clinical Endocrinology and Metabolism, Vol. 88, Núm. 7, pp. 3450-3453

2002

  1. Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy

    Obesity Research, Vol. 10, Núm. 7, pp. 682-687

  2. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans

    Clinical Endocrinology, Vol. 57, Núm. 2, pp. 265-271

  3. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans

    Clinical Endocrinology, Vol. 56, Núm. 5, pp. 643-648

2001

  1. Control and function of the GH-IGF-I axis in obesity

    Eating and Weight Disorders, Vol. 6, Núm. 3 SUPPL., pp. 22-27

  2. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone

    Journal of Clinical Endocrinology and Metabolism, Vol. 86, Núm. 3, pp. 1169-1174

  3. Involvement of nitric oxide in the regulation of growth hormone secretion in dogs

    Neuroendocrinology, Vol. 74, Núm. 4, pp. 213-219

2000

  1. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans

    Journal of Endocrinological Investigation, Vol. 23, Núm. 8, pp. 493-495

  2. Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 279, Núm. 2 42-2

1993

  1. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: Studies with GH-releasing hormone, pyridostigmine, and arginine

    Journal of Clinical Endocrinology and Metabolism, Vol. 77, Núm. 3, pp. 616-620

  2. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women

    Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 2, pp. 374-377